whether Lantus increases cancer risk
August 2009
Patients are asking whether Lantus increases cancer risk.
Recent European studies suggest a higher cancer risk in patients using Lantus (insulin glargine) ALONE compared to other insulins.
A Swedish study suggests one extra case of breast cancer for every 1000 women using Lantus alone for 1 year compared to other insulins.
Upgrade now to access this resource
This content is not available under the subscriptions purchased by your organization, but you can add it on!
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive